-+ 0.00%
-+ 0.00%
-+ 0.00%

Traws Pharma Defers Planned Phase 2a Influenza Study Of Tivoxavir Marboxil After Negative UK MHRA Review; Cash Runway Extends To Q1 2027; Advancing Alternative Influenza Antiviral Candidates

Benzinga·06/12/2026 21:30:14
Listen to the news

-SEC Filing